Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eli-Lilly
Company Monitoring Page for Eli-Lilly
latest headlines for company on cafepharma
Obesity, diabetes drugs push Novo Nordisk and Eli Lilly to front of pharma's growth pack in Q2
Fierce Pharma
Wed, 08/16/23 - 10:05 am
Tags:
Novo Nordisk
,
Eli Lilly
,
obesity
,
diabetes
,
earnings
Eli Lilly and Company completes acquisition of Versanis Bio
Pharmaceutical Business Review
Tue, 08/15/23 - 10:01 am
Tags:
Eli Lilly
,
Versanis Bio
,
M&A
Eli Lilly raises full-year guidance as Mounjaro, other drugs drive second-quarter profit up 85%
CNBC
Tue, 08/8/23 - 11:43 am
Tags:
Eli Lilly
,
earnings
,
Mounjaro
Report: Fewer Adults Are Interested in Weight Loss Drugs If Not Covered by Insurance
MedCity News
Mon, 08/7/23 - 11:12 pm
Tags:
insurance
,
weight loss
,
payers
,
Novo Nordisk
,
Eli Lilly
Eli Lilly meets primary endpoint in LIBRETTO-431 study for NSCLC
Clinical Trials Arena
Mon, 08/7/23 - 10:25 am
Tags:
Eli Lilly
,
clinical trials
,
Retevmo
,
non-small cell lung cancer
,
Keytruda
Novo Nordisk, Eli Lilly face injury lawsuit from user of popular GLP-1 medicines
Fierce Pharma
Thu, 08/3/23 - 06:44 pm
Tags:
Novo Nordisk
,
Eli Lilly
,
Mounjaro
,
Ozempic
,
legal
,
side effects
Spotlight – Nash in 2023 and beyond
EP Vantage
Thu, 08/3/23 - 10:03 am
Tags:
NASH
,
Boehringer Ingelheim
,
Zealand Pharma
,
Akero Therapeutics
,
Axcella Health
,
Eli Lilly
,
Pfizer
,
Ionis Pharmaceuticals
,
Cascade
,
AstraZeneca
,
Gilead Sciences
,
Novo Nordisk
,
Ascletis Pharma
,
MediciNova
Lilly's obesity drug leads to about 26% weight loss in new studies
Yahoo/Reuters
Thu, 07/27/23 - 11:41 am
Tags:
Eli Lilly
,
obesity
,
clinical trials
,
Mounjaro
Eli Lilly's Mounjaro shortage worsens ahead of potential obesity FDA approval
Fierce Pharma
Wed, 07/26/23 - 11:26 am
Tags:
Eli Lilly
,
Mounjaro
,
obesity
,
weight loss
,
drug shortages
Jardiance cleared in EU for CKD, challenging Forxiga
Pharmaphorum
Wed, 07/26/23 - 09:45 am
Tags:
Boehringer Ingelheim
,
Eli Lilly
,
Jardiance
,
Europe
,
chronic kidney disease
,
Forxiga
New weight loss drugs carry high price tags and lots of questions for seniors
Medical Marketing and Media
Tue, 07/25/23 - 08:53 pm
Tags:
Seniors
,
Wegovy
,
Novo Nordisk
,
Mounjaro
,
Eli Lilly
,
weight loss
Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
BioSpace
Mon, 07/24/23 - 09:57 am
Tags:
neurodegenerative disease
,
Alzheimer's disease
,
Axsome Therapeutics
,
Eli Lilly
,
Anavex
,
TauRx
,
AB Science
,
ALS
,
BrainStorm Cell Therapeutics
,
Seelos Therapeutics
,
Parkinson's Disease
,
AbbVie
,
Mitsubishi Tanabe Pharma
,
Annovis
,
Huntington's disease
,
Prilenia Therapeutics
,
Neurocrine
Novo Nordisk, Eli Lilly and Boehringer Ingelheim back bill to bring obesity drug coverage to Medicare
Fierce Pharma
Thu, 07/20/23 - 09:42 pm
Tags:
Novo Nordisk
,
Eli Lilly
,
Boehringer Ingelheim
,
obesity
Lilly’s donanemab flaunts strong clinical profile, ready to compete with Leqembi
Clinical Trials Arena
Wed, 07/19/23 - 10:27 am
Tags:
Eli Lilly
,
donanemab
,
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
Eli Lilly partners with Team U.S.A. through 2028 Olympic Games in Los Angeles
Medical Marketing and Media
Mon, 07/17/23 - 06:52 pm
Tags:
Eli Lilly
,
Olympics
,
pharma marketing
Lilly shares full pivotal data on Alzheimer’s drug, revealing how it shapes up against Leqembi
Fierce Biotech
Mon, 07/17/23 - 06:51 pm
Tags:
Eli Lilly
,
Alzheimer's disease
,
clinical trials
,
FDA
,
donanemab
AbbVie, Lilly-backed Capsida cuts staff months after signing Big Pharma deals
Fierce Biotech
Sun, 07/16/23 - 02:37 pm
Tags:
Capsida Biotherapeutics
,
layoffs
,
gene therapy
,
AbbVie
,
Eli Lilly
Hungry for more, Lilly tops off weight loss pipeline with $1.9B deal to acquire Versanis
Fierce Biotech
Fri, 07/14/23 - 10:10 am
Tags:
Eli Lilly
,
M&A
,
obesity
,
Versanis
,
bimagrumab
Lilly, Novo, BMS return to boost BGV's largest European biotech fund yet
Fierce Biotech
Thu, 07/13/23 - 10:15 am
Tags:
Eli Lilly
,
Novo Holdings
,
Bristol Myers Squibb
,
venture capital
,
funding
,
BGV
,
Europe
After First Approval, Experts Point to Barriers in Cell Therapy for Type 1 Diabetes
BioSpace
Thu, 07/13/23 - 10:11 am
Tags:
CellTrans
,
Lantidra
,
type 1 diabetes
,
cell therapy
,
Eli Lilly
,
Siglion Therapeutics
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.